The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Abstract
An age-dependent decline in skeletal muscle mass, strength, and endurance during the aging process is a physiological development, but several factors may exacerbate this process, leading to the threatening state of sarcopenia, frailty, and eventually higher mortality rates. Obesity appears to be such a promoting factor and has been linked in several studies to sarcopenia. The reason for this causal association remains poorly understood. Notwithstanding the fact that a higher body mass might simply lead to diminished physical activity and therefore contribute to a decline in skeletal muscle, several molecular mechanisms have been hypothesized. There could be an obesity derived intracellular lipotoxicity (i.e., elevated intramuscular levels of lipids and their derivatives), which induces apoptosis by means of an elevated oxidative stress. Paracrine mechanisms and inflammatory cytokines, such as CRP and IL-6 could be confounders of the actual underlying pathological mechanism. Due to a cross-talk of the hypothalamo-pituitary axis with nutritional status, obese subjects are more in a catabolic state of metabolism, with a higher susceptibility to muscle wasting under energy restriction. Obesity induces insulin resistance in the skeletal muscle, which consequently leads to perturbed metabolism, and misrouted signaling in the muscle cells. In obesity, muscle progenitor cells could differentiate to an adipocyte-like phenotype as a result of paracrine signals from (adipo)cytokines leading to a reduced muscular renewal capacity. The present review outlines current knowledge concerning possible pathways, which might be involved in the molecular pathogenesis of sarcopenic obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The regeneration potential of muscle is impaired, which might promote fibrosis, thereby promoting insulin resistance76–79, partially owing to impaired mitochondrial fatty acid oxidation and increased lipolysis76,80.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [77]
In the citing paper
“These cytokines induce muscle atrophy by increasing apoptosis and upregulating proteosomal decay of filament proteins [42].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [42]
In the citing paper
“Thus, SO decreases the physical functional capacity to a higher degree than sarcopenia or obesity separately [13, 14].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [14]
In the citing paper
“Also, adiponectin and growth hormone (GH) decrease their secretion in obesity and aging, inducing adverse effects on muscle protein synthesis.”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [14]
In the citing paper
“TNF-α is a proinflammatory cytokine that increases in aging and obesity, promotes protein degradation, decreases protein synthesis, and inhibits myogenic differentiation [14, 45].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [14]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M., & Moraes, C. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911570106 · Cited by 600 · cited 3×
“Transgene animals showed a lower fat percentage, together with a higher mitochondrial capacity and a higher capacity for oxidative phosphorylation and increased insulin sensitivity, suggesting a PGC-1a-mediated mitochondrial dysfunction in muscular aging (Wenz et al. 2009).”
BackgroundInfluentialRetractedSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 4×
“8 or\1 m/s) for diagnosing of sarcopenia (Cruz-Jentoft et al. 2010; Fielding et al. 2011).”
BackgroundInfluentialAging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567 · cited 2×
“increased reactive oxygen species formation (ROS), an age-dependent decrease in central mitochondrial regulator peroxisome-proliferator-activated-receptor-c coactivator 1 a (PGC-1a) and induced mitochondrial apoptosis of muscle cells are important (Harman 1956; Anderson and Prolla 2009; Marzetti et al. 2010).”
BackgroundAmerican College of Sports Medicine position stand
Otis, C. L. (1997) · Medical Entomology and Zoology · Cited by 4,407
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 3×
“Adiponectin increases insulin sensitivity by facilitating glucose uptake in skeletal muscle and adipose tissue and stimulates fatty acid oxidation (Yamauchi et al. 2002).”
BackgroundFielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 3×
“8 or\1 m/s) for diagnosing of sarcopenia (Cruz-Jentoft et al. 2010; Fielding et al. 2011).”
BackgroundInfluentialSelf-citationAdipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188 · cited 6×
“It decreases the inflammatory response by inhibiting TNFa and interleukin-c (ILc) secretion and elevates production of anti-inflammatory cytokines, such as IL-10 and IL-1 receptor antagonist, by human monocytes, macrophages, and dendritic cells (Tilg and Moschen 2006).”
BackgroundInfluentialCloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
DONNELLY, J. E., BLAIR, S. N., JAKICIC, J. M., MANORE, M. M., RANKIN, J. W., & SMITH, B. K. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181949333 · Cited by 2,658 · cited 1×
“Actually in older people with obesity, it leads to muscle mass gain and improves body composition (Donnelly et al. 2009).”
BackgroundMuscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388 · cited 1×
“After release in the blood stream, IL-6 enhances gluconeogenesis in the liver and lipolysis in adipose tissue (Pedersen and Febbraio 2008).”
BackgroundSt-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233 · cited 2×
“Transcription factor PGC-1a decreases ROS formation (St-Pierre et al. 2006), equilibrates lipid oxidation and synthesis with direct effects on IMCL levels (Espinoza et al. 2010) and promotes mitochondrial biogenesis (Wende et al. 2007).”
BackgroundWisløff, U., Støylen, A., Loennechen, J. P., Bruvold, M., Rognmo, Ø., Haram, P. M., Tjønna, A. E., Helgerud, J., Slørdahl, S. A., Lee, S. J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675041 · Cited by 1,996 · cited 2×
“Mitochondrial biogenesis and lipidoxidation and synthesis are improved by HIT via increased levels of PGC-1a in skeletal muscle (Wisloff et al. 2007).”
BackgroundMuscaritoli, M., Anker, S. D., Argilés, J., Aversa, Z., Bauer, J. M., Biolo, G., Boirie, Y., Bosaeus, I., Cederholm, T., Costelli, P., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.004 · Cited by 1,732 · cited 1×
“In the development of sarcopenia atrophy of muscle fibers, especially type II fibers occurs and the number of motor neuron decreases (Muscaritoli et al. 2010).”
BackgroundSelf-citationHigh-Intensity Strength Training in Nonagenarians: Effects on Skeletal Muscle
Fiatarone, M. A. (1990) · JAMA · doi:10.1001/jama.1990.03440220053029 · Cited by 1,593 · cited 1×
“Resistance training reduces body weight and enhances muscle strength and mass effectively in aging individuals (Frontera et al. 1988; Fiatarone et al. 1990).”
BackgroundStrength conditioning in older men: skeletal muscle hypertrophy and improved function
Frontera, W. R., Meredith, C. N., O'Reilly, K. P., Knuttgen, H. G., & Evans, W. J. (1988) · Journal of Applied Physiology · doi:10.1152/jappl.1988.64.3.1038 · Cited by 1,384
IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267 · cited 1×
“DAG, long chain acyl CoA, and ceramides are a biochemical link between increase in IMCL and insulin resistance (Griffin et al. 1999; Choi et al. 2008).”
BackgroundKrssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264 · cited 1×
“These intramyocellular lipids (IMCL) are associated with decreased insulin sensitivity (Jacob et al. 1999; Krssak et al. 1999).”
BackgroundGoodpaster, B. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5755 · Cited by 1,194 · cited 3×
“In the case of a permanent positive fat balance, the storage of intracellular fat is also not balanced by an increased oxidative capacity (Goodpaster et al. 2001).”
BackgroundInfluentialFatty acid-induced β cell apoptosis: A link between obesity and diabetes
Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142 · cited 4×
“Fat distribution changes with age so that there is an increase in visceral fat but also fat deposits occurs in skeletal muscle, the liver, heart and pancreas (Sakuma and Yamaguchi 2013; Wei et al. 2006; Shimabukuro et al. 1998; Sparangna and Hickson-bick 2000; Garris 2005; Summers 2006).”
BackgroundInfluentialGrowth Hormone and the Insulin-Like Growth Factor System in Myogenesis*
FLORINI, J. R., EWTON, D. Z., & COOLICAN, S. A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-5-481 · Cited by 1,142 · cited 1×
“Growth hormone (GH) coordinates the postnatal growth of different tissues, including skeletal muscle (Florini et al. 1996).”
BackgroundBody Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078 · cited 4×
“Aging is not only accompanied by a decline in muscle mass, but is also associated with an increasing fat mass, resulting in lower physical activity (Baumgartner 2000).”
BackgroundInfluentialSarcopenic obesity: definition, cause and consequences
Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328312c37d · Cited by 1,070
Inflammatory markers and loss of muscle mass (sarcopenia) and strength
Schaap, L. A., Pluijm, S. M. F., Deeg, D. J. H., & Visser, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.049 · Cited by 1,047 · cited 14×
“In summary, the role of inflammatory cytokines in the development of sarcopenic obesity is not well understood at present, since CRP and IL-6 could simply be confounders of the true underlying pathological mechanism.”
BackgroundInfluentialRegulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
Magnuson, B., Ekim, B., & Fingar, D. C. (2012) · Biochemical Journal · doi:10.1042/bj20110892 · Cited by 1,015 · cited 3×
“Secondly, proteins are degraded, mainly by the proteasomal or the lysosomal pathway, to utilize the liberated amino acids for new protein synthesis or for energy production (Magnuson et al. 2012).”
BackgroundSarcopenic obesity: A new category of obesity in the elderly
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.002 · Cited by 953 · cited 2×
“Increased levels of inflammatory molecules like TNFa and IL-6 have catabolic effects on skeletal muscle mass and are involved in sarcopenia (Zamboni et al. 2008; Waters et al. 2010).”
BackgroundSarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937 · cited 1×
“Sarcopenic obesity denotes the combination of sarcopenia and obesity, which means a concomitant overriding of abnormal age-dependent muscle loss and fat accumulation (Baumgartner et al. 2004; Bouchard et al. 2009).”
BackgroundThe weight of leptin in immunity
Cava, A. L., & Matarese, G. (2004) · Nature Reviews Immunology · doi:10.1038/nri1350 · Cited by 927 · cited 1×
“In addition to this function, leptin regulates neuroendocrine function, energy homeostasis, haematopoiesis, and angiogenesis , and is a mediator of immune-mediated diseases and inflammatory processes (La Cava and Matarese 2004).”
BackgroundCeramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848 · cited 4×
“Fat distribution changes with age so that there is an increase in visceral fat but also fat deposits occurs in skeletal muscle, the liver, heart and pancreas (Sakuma and Yamaguchi 2013; Wei et al. 2006; Shimabukuro et al. 1998; Sparangna and Hickson-bick 2000; Garris 2005; Summers 2006).”
BackgroundInfluentialREGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819
Wei, Y., Wang, D., Topczewski, F., & Pagliassotti, M. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00644.2005 · Cited by 735 · cited 4×
“Fat distribution changes with age so that there is an increase in visceral fat but also fat deposits occurs in skeletal muscle, the liver, heart and pancreas (Sakuma and Yamaguchi 2013; Wei et al. 2006; Shimabukuro et al. 1998; Sparangna and Hickson-bick 2000; Garris 2005; Summers 2006).”
BackgroundInfluentialCeramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
Adams, J. M., Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C., & Mandarino, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.1.25 · Cited by 668 · cited 1×
“In obesity, high circulating levels of lipids accumulate in skeletal muscle as triacylglycerol or derivates, such as diacylglycerol (DAG), long chain acyl CoA, and ceramide (Adams et al. 2004; Watt et al. 2006).”
BackgroundHealth consequences of obesity in the elderly: a review of four unresolved questions
Zamboni, M., Mazzali, G., Zoico, E., Harris, T. B., Meigs, J. B., Di Francesco, V, Fantin, F., Bissoli, L., & Bosello, O. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803005 · Cited by 649 · cited 1×
“Loss of lean body mass, reduced immune function, cognitive decline, accelerated atherosclerosis and insulin resistance are the consequences of this lowgrade inflammatory state (Kennedy et al. 2004; Zamboni et al. 2005; Florez and Troen 2008; Zamboni et al. 2008; Waters et al. 2010).”
BackgroundJacob, S., Machann, J., Rett, K., Brechtel, K., Volk, A., Renn, W., Maerker, E., Matthaei, S., Schick, F., Claussen, C. D., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1113 · Cited by 643 · cited 1×
“These intramyocellular lipids (IMCL) are associated with decreased insulin sensitivity (Jacob et al. 1999; Krssak et al. 1999).”
BackgroundLandi, F., Cruz-Jentoft, A. J., Liperoti, R., Russo, A., Giovannini, S., Tosato, M., Capoluongo, E., Bernabei, R., & Onder, G. (2013) · Age and Ageing · doi:10.1093/ageing/afs194 · Cited by 619 · cited 1×
“Sarcopenia is a functionally relevant decline of muscle mass and function and is closely related to physical disability and a propensity to have falls and has even been linked to increased mortality (Cooper et al. 2011; Landi et al. 2013; Batsis et al. 2014).”
BackgroundTestosterone administration to elderly men increases skeletal muscle strength and protein synthesis
Urban, R. J., Bodenburg, Y. H., Gilkison, C., Foxworth, J., Coggan, A. R., Wolfe, R. R., & Ferrando, A. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.5.e820 · Cited by 608 · cited 3×
“to increase levels to ranges similar to young men elevates skeletal muscle strength and protein synthesis (Urban et al. 1995).”
BackgroundInfluentialSarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594 · cited 7×
“Consistent with this, C-reactive protein (CRP) and IL6 are positively correlated with obesity, particularly with central obesity (Schrager et al. 2007).”
BackgroundInfluentialAging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis
Reznick, R. M., Zong, H., Li, J., Morino, K., Moore, I. K., Yu, H. J., Liu, Z.-X., Dong, J., Mustard, K. J., Hawley, S. A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.008 · Cited by 555 · cited 2×
“However, an age-dependent increase in IMCL is primarily based on mitochondrial dysfunction, which it is claimed is an essential element of the pathogenesis of sarcopenia (Reznick et al. 2007).”
BackgroundHigh-Intensity Intermittent Exercise and Fat Loss
Boutcher, S. H. (2011) · Journal of Obesity · doi:10.1155/2011/868305 · Cited by 538 · cited 4×
“Mitochondrial biogenesis and lipidoxidation and synthesis are improved by HIT via increased levels of PGC-1a in skeletal muscle (Wisloff et al. 2007).”
BackgroundInfluentialTrapp, E. G., Chisholm, D. J., Freund, J., & Boutcher, S. H. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803781 · Cited by 533 · cited 1×
“This exercise reduces body mass, waist circumference, subcutaneous and abdominal fat Boutcher 2011) besides increasing muscle mass (Tapp et al. 2008; Boudou et al. 2003).”
BackgroundEmmelot-Vonk, M. H., Verhaar, H. J. J., Nakhai Pour, H. R., Aleman, A., Lock, T. M. T. W., Bosch, J. L. H. R., Grobbee, D. E., & van der Schouw, Y. T. (2008) · JAMA · doi:10.1001/jama.2007.51 · Cited by 518
Lipid accumulation in non-adipose tissue and lipotoxicity
van Herpen, N. A., & Schrauwen-Hinderling, V. B. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.049 · Cited by 500 · cited 2×
“Elevated levels of palmitic acid correlate with de novo synthesis of ceramides and cause activation of apoptotic pathways in several cell types, including the b-cells (Van Herpen and Schrauwen-Hinderling 2008).”
BackgroundBatsis, J. A., Mackenzie, T. A., Barre, L. K., Lopez-Jimenez, F., & Bartels, S. J. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.117 · Cited by 479 · cited 1×
“Sarcopenia is a functionally relevant decline of muscle mass and function and is closely related to physical disability and a propensity to have falls and has even been linked to increased mortality (Cooper et al. 2011; Landi et al. 2013; Batsis et al. 2014).”
BackgroundObjective measures of physical capability and subsequent health: a systematic review
Cooper, R., Kuh, D., Cooper, C., Gale, C. R., Lawlor, D. A., Matthews, F., Hardy, R., & Teams, T. F. A. H. S. (2011) · Age and Ageing · doi:10.1093/ageing/afq117 · Cited by 473 · cited 1×
“Sarcopenia is a functionally relevant decline of muscle mass and function and is closely related to physical disability and a propensity to have falls and has even been linked to increased mortality (Cooper et al. 2011; Landi et al. 2013; Batsis et al. 2014).”
BackgroundRolland, Y., Lauwers-Cances, V., Cristini, C., van Kan, G. A., Janssen, I., Morley, J. E., & Vellas, B. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26950 · Cited by 465 · cited 3×
“In a landmark study by Rolland and colleagues, it was shown that sarcopenic obesity, in particular, leads to an increase in functional impairment , which was higher for sarcopenic obesity than either sarcopenia or obesity alone (Rolland et al. 2009).”
BackgroundApoptosis: mechanisms and clinical implications
Kam, P. C. A., & Ferch, N. I. (2000) · Anaesthesia · doi:10.1046/j.1365-2044.2000.01554.x · Cited by 455
Kohut, M. L., McCann, D. A., Russell, D. W., Konopka, D. N., Cunnick, J. E., Franke, W. D., Castillo, M. C., Reighard, A. E., & Vanderah, E. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.12.002 · Cited by 436 · cited 3×
“Consequential exercise and/ or strength training were described as being effective anti-inflammatory therapies for improving muscle function (Kohut et al. 2006; Donges et al. 2010; Nicklas et al. 2008).”
BackgroundCellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness
Ryall, J. G., Schertzer, J. D., & Lynch, G. S. (2008) · Biogerontology · doi:10.1007/s10522-008-9131-0 · Cited by 423 · cited 2×
“Different signaling cascades are activated by GH and its decrease with age has numerous consequences for skeletal muscle structure and function (Ryall et al. 2008).”
BackgroundCesari, M., Kritchevsky, S. B., Baumgartner, R., Atkinson, H. H., Penninx, B. W. J. H., Lenchik, L., Palla, S. L., Ambrosius, W. T., Tracy, R. P., & Pahor, M. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.82.2.428 · Cited by 422 · cited 7×
“icantly correlation with high CRP and IL-6 levels after adaption for sarcopenia (Cesari et al. 2005).”
BackgroundInfluentialElabd, C., Cousin, W., Upadhyayula, P., Chen, R. Y., Chooljian, M. S., Li, J., Kung, S., Jiang, K. P., & Conboy, I. M. (2014) · Nature Communications · doi:10.1038/ncomms5082 · Cited by 411 · cited 3×
“Recently the hormone oxytocin was shown to be involved in muscle regeneration and homeostasis (Elabd et al. 2014).”
BackgroundInfluentialRegeneration of Mammalian Skeletal Muscle: Basic Mechanisms and Clinical Implications
Ciciliot, S., & Schiaffino, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790883453 · Cited by 385 · cited 1×
“Proliferation of satellite cells and fusion with existing myofibers to substitute or enhance myonuclei is the result of activation via muscle load (Ciciliot and Schiaffino 2010).”
BackgroundYarasheski, K. E., Bhasin, S., Sinha‐Hikim, I., Pak-Loduca, J., & González-Cadavid, N. F. (2002) · PubMed · Cited by 346
Batsis, J. A., Barre, L. K., Mackenzie, T. A., Pratt, S. I., Lopez‐Jimenez, F., & Bartels, S. J. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12260 · Cited by 330 · cited 3×
“Consequently , the percentage of participants over the age of 60 years meeting the criteria of sarcopenic obesity reached 4.4–84.0 % for men and 3.6–94.0 % for women (Batsis et al. 2013).”
BackgroundInfluentialIncreased secretion and expression of myostatin in skeletal muscle from extremely obese women
Hittel, D. S., Berggren, J. R., Shearer, J., Boyle, K., & Houmard, J. A. (2009) · Diabetes · doi:10.2337/db08-0943 · Cited by 324 · cited 2×
“Obesity and insulin resistance increase expression of myostatin in skeletal muscle (Hittel et al. 2009; Allen et al. 2011) and adipose tissue samples obtained from obese and extremely obese”
BackgroundBouchard, D. R., Dionne, I. J., & Brochu, M. (2009) · Obesity · doi:10.1038/oby.2009.109 · Cited by 314 · cited 3×
“Sarcopenic obesity denotes the combination of sarcopenia and obesity, which means a concomitant overriding of abnormal age-dependent muscle loss and fat accumulation (Baumgartner et al. 2004; Bouchard et al. 2009).”
BackgroundCatabolism of aging: is it an inflammatory process?
Roubenoff, R. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000068965.34812.62 · Cited by 305 · cited 4×
“This gathering of intramuscular fat infiltration results in worse lower extremity performance in elderly persons, independent of whole body fat mass and muscle crosssectional area (Roubenoff 2003).”
BackgroundInfluentialDiabetes and apoptosis: lipotoxicity
Kusminski, C. M., Shetty, S., Orci, L., Unger, R. H., & Scherer, P. E. (2009) · Apoptosis · doi:10.1007/s10495-009-0352-8 · Cited by 302 · cited 3×
“These effects are mediated by the activation of the 50-AMP-activated protein kinase (AMPK) signaling pathway (Yamauchi et al. 2002; Kusminski et al. 2009).”
BackgroundOxytocin receptor-deficient mice developed late-onset obesity
Takayanagi, Y., Kasahara, Y., Onaka, T., Takahashi, N., Kawada, T., & Nishimori, K. (2008) · Neuroreport · doi:10.1097/wnr.0b013e3283021ca9 · Cited by 294 · cited 1×
“In an animal model study, oxytocin-receptor-deficient mice developed late onset obesity with normal food intake (Takayanagi et al. 2008; Camerino 2009).”
BackgroundExercise Training and Plasma C‐Reactive Protein and Interleukin‐6 in Elderly People
Nicklas, B. J., Hsu, F., Brinkley, T. J., Church, T., Goodpaster, B. H., Kritchevsky, S. B., & Pahor, M. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01994.x · Cited by 286 · cited 3×
“Consequently, inversion of inflammatory Biogerontology (2015) 16:15–29 23 processes could be achieved, at least in part, by combined exercise training in frail, obese older adults (Lambert et al. 2008; Nicklas et al. 2008; Donges et al. 2010).”
Choi, C. S., Befroy, D. E., Codella, R., Kim, S., Reznick, R. M., Hwang, Y.-J., Liu, Z.-X., Lee, H.-Y., Distefano, A., Samuel, V. T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810339105 · Cited by 279 · cited 2×
“DAG, long chain acyl CoA, and ceramides are a biochemical link between increase in IMCL and insulin resistance (Griffin et al. 1999; Choi et al. 2008).”
BackgroundCNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK
Watt, M. J., Dzamko, N., Thomas, W. G., Rose-John, S., Ernst, M., Carling, D., Kemp, B. E., Febbraio, M. A., & Steinberg, G. R. (2006) · Nature Medicine · doi:10.1038/nm1383 · Cited by 276 · cited 1×
“In obesity, high circulating levels of lipids accumulate in skeletal muscle as triacylglycerol or derivates, such as diacylglycerol (DAG), long chain acyl CoA, and ceramide (Adams et al. 2004; Watt et al. 2006).”
BackgroundMathus-Vliegen, E. M. H., Basdevant, A., Finer, N., Hainer, V., Hauner, H., Micic, D., Maislos, M., Roman, G., Schutz, Y., Tsigos, C., et al. (2012) · Obesity Facts · doi:10.1159/000341193 · Cited by 261
DONGES, C. E., DUFFIELD, R., & DRINKWATER, E. J. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181b117ca · Cited by 258 · cited 16×
“In summary, the role of inflammatory cytokines in the development of sarcopenic obesity is not well understood at present, since CRP and IL-6 could simply be confounders of the true underlying pathological mechanism.”
BackgroundInfluentialA role for the transcriptional coactivator PGC-1α in muscle refueling.
Wende, A. R., Schaeffer, P. J., Parker, G. J., Zechner, C., Han, D.-H., Chen, M. M., Hancock, C. R., Lehman, J. J., Huss, J. M., McClain, D. A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707006200 · Cited by 257 · cited 1×
“Transcription factor PGC-1a decreases ROS formation (St-Pierre et al. 2006), equilibrates lipid oxidation and synthesis with direct effects on IMCL levels (Espinoza et al. 2010) and promotes mitochondrial biogenesis (Wende et al. 2007).”
BackgroundMechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats
Deblon, N., Veyrat-Durebex, C., Bourgoin, L., Caillon, A., Bussier, A.-L., Petrosino, S., Piscitelli, F., Legros, J.-J., Geenen, V., Foti, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025565 · Cited by 254 · cited 2×
“Probably, oxytocin plays essential roles in the regulation of energy homeostasis and the administration of oxytocin may be a promising therapeutic approach for the treatment of human obesity and type 2 diabetes (Deblon et al. 2011).”
BackgroundMethodLambert, C. P., Wright, N. R., Finck, B. N., & Villareal, D. T. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00006.2008 · Cited by 249 · cited 5×
“Consequently, inversion of inflammatory Biogerontology (2015) 16:15–29 23 processes could be achieved, at least in part, by combined exercise training in frail, obese older adults (Lambert et al. 2008; Nicklas et al. 2008; Donges et al. 2010).”
BackgroundInfluentialLow sympathetic tone and obese phenotype in oxytocin-deficient mice
Camerino, C. (2009) · Obesity · doi:10.1038/oby.2009.12 · Cited by 235 · cited 1×
“In an animal model study, oxytocin-receptor-deficient mice developed late onset obesity with normal food intake (Takayanagi et al. 2008; Camerino 2009).”
BackgroundRecent advances in growth hormone signaling
Lanning, N. J., & Carter-Su, C. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9025-5 · Cited by 232 · cited 2×
“GH acts directly via the GH receptor which activates different signaling pathways (Lanning and Carter-Su 2006), but also indirectly via liver-derived IGF-I as a downstream target for GH-mediated transcription (Chia et al.”
BackgroundAging and Regional Differences in Fat Cell Progenitors – A Mini-Review
Sepe, A., Tchkonia, T., Thomou, T., Zamboni, M., & Kirkland, J. L. (2011) · Gerontology · doi:10.1159/000279755 · Cited by 232 · cited 4×
“Adipocytes and to an even higher extent proadipocytes themselves have also been shown to express IL6, tumor necrosis factor a (TNFa) and monocyte chemotactic protein-1 (MCP-1; Sepe et al. 2011).”
BackgroundInfluentialExercise attenuates the weight-loss-induced reduction in muscle mass in frail obese older adults
FRIMEL, T. N., SINACORE, D. R., & VILLAREAL, D. T. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31816a85ce · Cited by 230 · cited 1×
“Exercise training has a beneficial effect on muscle strength and physical activity (Frimel et al. 2008) and may affect different aspects of sarcopenic obesity.”
BackgroundQuinn, L. S., Anderson, B. G., Drivdahl, R. H., Alvarez, B., & Argilés, J. M. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5624 · Cited by 226 · cited 1×
“IL-15 is an anabolic cytokine that stimulates protein synthesis while stunting proteolysis in cultured myotubes (Quinn et al. 2002).”
BackgroundFujita, S., Rasmussen, B. B., Cadenas, J. G., Drummond, M. J., Glynn, E. L., Sattler, F. R., & Volpi, E. (2007) · Diabetes · doi:10.2337/db06-1566 · Cited by 224 · cited 2×
“Consequently , endurance training results in recovery of skeletal muscle sensitivity to the anabolic effect of insulin (Fujita et al. 2007), increased mitochondrial function (Lanza and Nair 2009), decreased circulating myostatin (Argiles et al. 2012), upregulated muscle protein synthesis (Villareal…”
BackgroundWaters, D. (2010) · Clinical Interventions in Aging · doi:10.2147/cia.s6920 · Cited by 220
Zhang, G., Bai, H., Zhang, H., Dean, C., Wu, Q., Li, J., Guariglia, S., Meng, Q., & Cai, D. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.036 · Cited by 208 · cited 1×
“Otherwise, a central oxytocin infusion in diet-induced obese mice results in a body weight loss (Zhang et al. 2011).”
BackgroundExpression and function of myostatin in obesity, diabetes, and exercise adaptation
ALLEN, D. L., HITTEL, D. S., & MCPHERRON, A. C. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182178bb4 · Cited by 207 · cited 2×
“Obesity and insulin resistance increase expression of myostatin in skeletal muscle (Hittel et al. 2009; Allen et al. 2011) and adipose tissue samples obtained from obese and extremely obese”
BackgroundProgressive resistance strength training for physical disability in older people
Latham, N. K., Anderson, C. S., Bennett, D. A., & Stretton, C. (2003) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002759 · Cited by 207 · cited 1×
“In summary, resistance exercise has a high potential for the effective treatment of sarcopenia because it improves muscle performance and functional capacity as clinically important outcome parameters (Latham et al. 2003).”
BackgroundA metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis
Sparagna, G. C., Hickson-Bick, D. L., Buja, L. M., & McMillin, J. B. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.5.h2124 · Cited by 205 · cited 4×
“Fat distribution changes with age so that there is an increase in visceral fat but also fat deposits occurs in skeletal muscle, the liver, heart and pancreas (Sakuma and Yamaguchi 2013; Wei et al. 2006; Shimabukuro et al. 1998; Sparangna and Hickson-bick 2000; Garris 2005; Summers 2006).”
BackgroundInfluentialChen, M. B., McAinch, A. J., Macaulay, S. L., Castelli, L. A., O’Brien, P. E., Dixon, J. B., Cameron-Smith, D., Kemp, B. E., & Steinberg, G. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1980 · Cited by 200 · cited 1×
“Activation of AMPK signaling is reduced in obesity, due to the lack of adiponectin, although expression of ADIPOR1 and ADIPOR2 is similar (Chen et al. 2005).”
BackgroundHerbst, A., Pak, J. W., McKenzie, D., Bua, E., Bassiouni, M., & Aiken, J. M. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.3.235 · Cited by 200 · cited 1×
“Apart from lipids, mitochondrial DNA (mtDNA) may be a target for oxidative stress (Herbst et al. 2007).”
BackgroundMyostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review
White, T. A., & LeBrasseur, N. K. (2014) · Gerontology · doi:10.1159/000356740 · Cited by 191 · cited 1×
“Therefore, the possibility of using myostatin as a potential target for the therapy of sarcopenia deserves further investigation (White and LeBrasseur 2014).”
BackgroundSarcopenic obesity and endocrinal adaptation with age
Sakuma, K., & Yamaguchi, A. (2013) · International Journal of Endocrinology · doi:10.1155/2013/204164 · Cited by 189 · cited 5×
“In contrast to adiponectin, leptin, another major adipokine, is positively correlated with fat mass (Sakuma and Yamaguchi 2013).”
BackgroundInfluentialBoudou, P., Sobngwi, E., Mauvais-Jarvis, F., Vexiau, P., & Gautier, J. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490421 · Cited by 188 · cited 1×
“This exercise reduces body mass, waist circumference, subcutaneous and abdominal fat Boutcher 2011) besides increasing muscle mass (Tapp et al. 2008; Boudou et al. 2003).”
BackgroundLevine, M. E., & Crimmins, E. M. (2012) · Obesity · doi:10.1038/oby.2012.20 · Cited by 186 · cited 2×
“In line with this, in a recent study by Levine and Crimmins (2012), CRP was not able to significantly vary the power to predict physical functioning problems in either the group of solely sarcopenic, solely obese or sarcopenic obese participants, even though a correlation of CRP levels and the risk…”
BackgroundResultSkeletal muscle: an endocrine organ
Pratesi, A. (2013) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2013.10.1.011 · Cited by 185 · cited 1×
“Even though discussed as a negative predictor of muscle mass in obese elderly subjects, IL6 seems to have an anabolic and insulinsensitizing effect on muscle cells (Pratesi et al. 2013).”
BackgroundIntramuscular lipid metabolism, insulin action, and obesity
Consitt, L. A., Bell, J. A., & Houmard, J. A. (2009) · IUBMB Life · doi:10.1002/iub.142 · Cited by 180 · cited 2×
“, insulin-receptor substrate or protein kinase B and may inhibit insulin signal transduction (Consitt et al. 2009).”
BackgroundMitochondrial death effectors: Relevance to sarcopenia and disuse muscle atrophy
Marzetti, E., Hwang, J. C. Y., Lees, H. A., Wohlgemuth, S. E., Dupont-Versteegden, E. E., Carter, C. S., Bernabei, R., & Leeuwenburgh, C. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.05.007 · Cited by 174 · cited 3×
“increased reactive oxygen species formation (ROS), an age-dependent decrease in central mitochondrial regulator peroxisome-proliferator-activated-receptor-c coactivator 1 a (PGC-1a) and induced mitochondrial apoptosis of muscle cells are important (Harman 1956; Anderson and Prolla 2009; Marzetti et al. 2010).”
BackgroundAre Human and Mouse Satellite Cells Really the Same?
Boldrin, L., Muntoni, F., & Morgan, J. E. (2010) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2010.956201 · Cited by 174 · cited 1×
“Boldrin et al. (2010) highlighted the differences and similarities between human and mouse satellite cells.”
BackgroundMuscle mitochondrial changes with aging and exercise
Lanza, I. R., & Nair, K. S. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26717d · Cited by 169 · cited 2×
“…results in recovery of skeletal muscle sensitivity to the anabolic effect of insulin (Fujita et al. 2007), increased mitochondrial function (Lanza and Nair 2009), decreased circulating myostatin (Argiles et al. 2012), upregulated muscle protein synthesis (Villareal et al. 2011) and…”
BackgroundPGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162 · cited 1×
“…oxygen species formation (ROS), an age-dependent decrease in central mitochondrial regulator peroxisome-proliferator-activated-receptor-c coactivator 1 a (PGC-1a) and induced mitochondrial apoptosis of muscle cells are important (Harman 1956; Anderson and Prolla 2009; Marzetti et al. 2010).”
BackgroundExercise, Amino Acids, and Aging in the Control of Human Muscle Protein Synthesis
Walker, D. K., Dickinson, J. M., Timmerman, K. L., Drummond, M. J., Reidy, P. T., Fry, C. S., Gundermann, D. M., & Rasmussen, B. B. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318223b037 · Cited by 157 · cited 1×
“Resistance training directly increases human skeletal muscle protein synthesis and causes muscle hypertrophy (Walker et al. 2011).”
BackgroundCurrent understanding of sarcopenia: possible candidates modulating muscle mass
Sakuma, K., Aoi, W., & Yamaguchi, A. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1527-x · Cited by 148 · cited 2×
“muscle health and systemic metabolism in older individuals (Sakuma et al. 2014).”
BackgroundVolkert, D. (2013) · Gerontology · doi:10.1159/000346142 · Cited by 143 · cited 1×
“Therefore, apparently the intake of essential nutrients shows tendentially an uncoupling from the actual requirement in old people (Volkert 2013).”
BackgroundDerbré, F., Gómez‐Cabrera, M. C., Nascimento, A. L. R., Sanchis‐Gomar, F., Martinez-Bello, V. E., Tresguerres, J. A. F., Fuentes, T., Gratas‐Delamarche, A., Monsalve, M., & Viña, J. (2011) · AGE · doi:10.1007/s11357-011-9264-y · Cited by 142 · cited 1×
“These inducers fail to up-regulate PGC-1a and its downstream effector nuclear response factor-1 (NRF1) in old rats, resulting in low mitochondrial biogenesis (Derbré et al. 2012).”
BackgroundSarcopenic obesity: how do we treat it?
Bouchonville, M. F., & Villareal, D. T. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000433071.11466.7f · Cited by 141 · cited 1×
“At present, the most successful treatment for sarcopenic obesity is regular multi-component exercise training combined with a diet-induced waste loss and maintenance of an adequate protein supply (Thornell 2011; Bouchonville and Villareal 2013).”
BackgroundVillareal, D. T., Smith, G. I., Sinacore, D. R., Shah, K., & Mittendorfer, B. (2011) · Obesity · doi:10.1038/oby.2010.110 · Cited by 140 · cited 4×
“…et al. 2007), increased mitochondrial function (Lanza and Nair 2009), decreased circulating myostatin (Argiles et al. 2012), upregulated muscle protein synthesis (Villareal et al. 2011) and enhancement of nutrient stimulated vasodilatation and nutrient delivery to muscle (Timmerman et al. 2012).”
InfluentialKok, P., Roelfsema, F., Langendonk, J. G., Frölich, M., Burggraaf, J., Meinders, A. E., & Pijl, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0920 · Cited by 132 · cited 2×
“Central adiposity elevates whole body metabolism and resting energy expenditure through up-regulation of the hypothalamo-pituitary-thyroid axis (Kok et al. 2005).”
BackgroundKadi, F., & Ponsot, E. (2009) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2009.00966.x · Cited by 126 · cited 2×
“Even though there have been conflicting results regarding the changes in satellite cell numbers during aging, most studies have reported a decrease in these progenitor cells throughout an individual‘s lifetime (Kadi and Ponsol 2010).”
ResultMyostatin: more than just a regulator of muscle mass
Argilés, J. M., Orpí, M., Busquets, S., & López-Soriano, F. J. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.02.001 · Cited by 125 · cited 2×
“2007), increased mitochondrial function (Lanza and Nair 2009), decreased circulating myostatin (Argiles et al. 2012), upregulated muscle protein synthesis (Villareal et al.”
BackgroundExamination of ‘lipotoxicity’ in skeletal muscle of high‐fat fed and ob / ob mice
Turpin-Nolan, S. M., Ryall, J. G., Southgate, R. J., Darby, I. A., Hevener, A. L., Febbraio, M. A., Kemp, B. E., Lynch, G. S., & Watt, M. J. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.166033 · Cited by 123 · cited 2×
“In contrast, the mean diameter of all three fiber types (type I; IIA and IIB) was evenly elevated for the group of mice that had a higher intake of dietary fat (Turpin et al. 2009).”
BackgroundStenholm, S., Rantanen, T., Heliövaara, M., & Koskinen, S. V. P. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01567.x · Cited by 123 · cited 3×
“…have indicated that insulin resistance may underlie the development of sarcopenia and inflammatory (adipo)cytokines, as well as growth hormone, testosterone, and high levels of circulating free fatty acids appear to play a role in the development of sarcopenic obesity (Stenholm et al. 2008a).”
BackgroundVilarrasa, N., Vendrell, J. J., Maravall, J., Broch, M., Estepa, A., Megía, A., Soler, J., Simón, I., Richart, C., & Gómez, J. M. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02346.x · Cited by 123 · cited 1×
“Serum concentrations of adiponectin are not only low in obesity, but additionally decreases with advancing age (Vilarrasa et al. 2005).”
BackgroundObesity in the elderly: who should we be treating, and why, and how?
Kennedy, R. L., Chokkalingham, K., & Srinivasan, R. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200401000-00002 · Cited by 121 · cited 1×
“Loss of lean body mass, reduced immune function, cognitive decline, accelerated atherosclerosis and insulin resistance are the consequences of this lowgrade inflammatory state (Kennedy et al. 2004; Zamboni et al. 2005; Florez and Troen 2008; Zamboni et al. 2008; Waters et al. 2010).”
BackgroundTimmerman, K. L., Dhanani, S., Glynn, E. L., Fry, C. S., Drummond, M. J., Jennings, K., Rasmussen, B. B., & Volpi, E. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.020800 · Cited by 120 · cited 2×
“…et al. 2007), increased mitochondrial function (Lanza and Nair 2009), decreased circulating myostatin (Argiles et al. 2012), upregulated muscle protein synthesis (Villareal et al. 2011) and enhancement of nutrient stimulated vasodilatation and nutrient delivery to muscle (Timmerman et al. 2012).”
BackgroundMarzetti, E., Carter, C. S., Wohlgemuth, S. E., Lees, H. A., Giovannini, S., Anderson, B., Quinn, L. S., & Leeuwenburgh, C. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.12.008 · Cited by 113 · cited 3×
“TNFa excreted either from adipose tissue or stimulated immune cells might induce apoptosis in muscle cells (Marzetti et al. 2009).”
BackgroundMethodInfluentialSainsbury, A., & Zhang, L. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00948.x · Cited by 105 · cited 3×
“Obese subjects, in particular, who have elevated levels of thyroid hormone, should have problems in adapting their resting energy expenditure in the short-term to actual demand (Sainsbury and Zhang 2012).”
BackgroundInfluentialAge standardization in mapping adult overweight and obesity trends in the WHO European Region
Doak, C. M., Wijnhoven, T. M. A., Schokker, D. F., Visscher, T. L. S., & Seidell, J. C. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00943.x · Cited by 96 · cited 1×
“Since about three out of four European adults are overweight, obesity will become an important challenge for the health system in the near future (Doak et al. 2012).”
BackgroundCochrane Review: Progressive resistance strength training for physical disability in older people
Latham, N. K., Anderson, C. S., Bennett, D., & Stretton, C. (2003) · Cochrane Database of Systematic Reviews · Cited by 93
TNF-α is involved in activating DNA fragmentation in skeletal muscle
Carbó, N., Busquets, S., van Royen, M. E., Alvarez, B., López-Soriano, F. J., & Argilés, J. M. A. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600167 · Cited by 91 · cited 1×
“Consequently, intraperitoneal administration of TNFa in rats for 8 days directly leads to apoptotic DNA laddering in muscle without external necrotic induction (Carbó et al. 2002).”
BackgroundAbnormal protein turnover and anabolic resistance to exercise in sarcopenic obesity
Nilsson, M. I., Dobson, J. P., Greene, N. P., Wiggs, M. P., Shimkus, K. L., Wudeck, E. V., Davis, A. R., Laureano, M. L., & Fluckey, J. D. (2013) · The FASEB Journal · doi:10.1096/fj.12-224006 · Cited by 87 · cited 2×
“Consistent with this, obese animals failed to adequately induce protein synthesis after stimulation (Nilsson et al. 2013).”
BackgroundChia, D. J., Ono, M., Woelfle, J., Massart, M., Jiang, H., & Rotwein, P. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510204200 · Cited by 86 · cited 1×
“GH acts directly via the GH receptor which activates different signaling pathways (Lanning and Carter-Su 2006), but also indirectly via liver-derived IGF-I as a downstream target for GH-mediated transcription (Chia et al. 2006).”
BackgroundSarcopenic obesity: satellite cells in the aging muscle
Thornell, L.-E. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283412260 · Cited by 86 · cited 2×
“The involvement of stem cells in the pathogenesis of sarcopenia and sarcopenic obesity are still a subject of debate, because of our incomplete understanding of human satellite cells (Thornell 2011).”
BackgroundBody composition, metabolic syndrome and testosterone in ageing men
Allan, C. A., Strauss, B. J. G., & McLachlan, R. I. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901552 · Cited by 67 · cited 1×
“Levels of this hormone decline with age and are individually influenced by nutrition and physical activity, with a trend towards decreasing in obese men (Sakuma and Yamaguchi 2013; Allan et al. 2007).”
BackgroundEspinoza, D., Boros, L. G., Crunkhorn, S., Gami, H., & Patti, M. (2009) · The FASEB Journal · doi:10.1096/fj.09-133728 · Cited by 66 · cited 1×
“Transcription factor PGC-1a decreases ROS formation (St-Pierre et al. 2006), equilibrates lipid oxidation and synthesis with direct effects on IMCL levels (Espinoza et al. 2010) and promotes mitochondrial biogenesis (Wende et al. 2007).”
BackgroundSummermatter, S., Thurnheer, R., Santos, G., Mosca, B., Baum, O., Treves, S., Hoppeler, H. H., Zorzato, F., & Handschin, C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00190.2011 · Cited by 60 · cited 1×
“The oxidative production of energy is maintained by the mitochondria, whose biogenesis is in turn driven by the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1a) (Summermatter et al. 2012).”
BackgroundSarcopenia in the aging high-fat fed rat: a pilot study for modeling sarcopenic obesity in rodents
Bollheimer, L. C., Buettner, R., Pongratz, G., Brunner-Ploss, R., Hechtl, C., Banas, M., Singler, K., Hamer, O. W., Stroszczynski, C., Sieber, C. C., et al. (2012) · Biogerontology · doi:10.1007/s10522-012-9405-4 · Cited by 58 · cited 5×
“Taken together, it is proposed that long-term feeding with a high fat diet decreases both S6K1, as well as 4EBP1 activity, resulting in deregulated muscle protein synthesis (Bollheimer et al. 2012).”
BackgroundInfluentialSelf-citationYeap, B. B., Paul Chubb, S. A., Lopez, D., Ho, K. K. Y., Hankey, G. J., & Flicker, L. (2013) · Clinical Endocrinology · doi:10.1111/cen.12052 · Cited by 53 · cited 1×
“Coincidence of low testosterone together with a decline in IGF-I has been shown to increase the probability of developing frailty (Yeap et al. 2012).”
BackgroundBuilding muscle, browning fat and preventing obesity by inhibiting myostatin
LeBrasseur, N. K. (2012) · Diabetologia · doi:10.1007/s00125-011-2361-8 · Cited by 46 · cited 1×
“Obesity and insulin resistance increase expression of myostatin in skeletal muscle (Hittel et al. 2009; Allen et al. 2011) and adipose tissue samples obtained from obese and extremely obese women revealed elevated levels of circulating myostatin (LeBrasseur 2012).”
BackgroundSakuma, K., Watanabe, K., Hotta, N., Koike, T., Ishida, K., Katayama, K., & Akima, H. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01995.x · Cited by 42 · cited 1×
“Muscle atrophy due to lower limb unloading for 2 weeks raises myostatin levels (Sakuma et al. 2009).”
BackgroundFat balance and serum leptin concentrations in normal, hypothyroid, and hyperthyroid rats
Iossa, S., Lionetti, L., Mollica, M. P., Crescenzo, R., Barletta, A., & Liverini, G. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801516 · Cited by 37 · cited 1×
“Accordingly, amino acids may be preferentially used as a fuel while protein synthesis is blocked (Iossa et al. 2001).”
BackgroundProtein Requirements in the Elderly
Volkert, D., & Sieber, C. C. (2011) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000061 · Cited by 35 · cited 3×
“Sarcopenia is also regarded as being a major component of frailty and may be promoted by disuse, altered endocrine function , chronic diseases, inflammation, insulin resistance , and malnutrition (Baumgartner 2000; Bouchard et al. 2009; Bollheimer et al. 2012; Volkert and Sieber 2011).”
BackgroundSelf-citationFellner, C., Schick, F., Kob, R., Hechtl, C., Vorbuchner, M., Büttner, R., Hamer, O. W., Sieber, C. C., Stroszczynski, C., & Bollheimer, L. C. (2014) · Gerontology · doi:10.1159/000360289 · Cited by 28 · cited 2×
“Nevertheless, the greater fiber area may possibly have been due to the short duration of the trial, since several other animal studies have found a decrease in muscle thickness which was seen to be dependent on obesity (Fellner et al. 2014).”
BackgroundSelf-citationFat and Inflammaging: A Dual Path to Unfitness in Elderly People?
Florez, H. J., & Troen, B. R. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01584.x · Cited by 28 · cited 1×
“Loss of lean body mass, reduced immune function, cognitive decline, accelerated atherosclerosis and insulin resistance are the consequences of this lowgrade inflammatory state (Kennedy et al. 2004; Zamboni et al. 2005; Florez and Troen 2008; Zamboni et al. 2008; Waters et al. 2010).”
BackgroundBallak, D. B., van Essen, P., van Diepen, J. A., Jansen, H., Hijmans, A., Matsuguchi, T., Sparrer, H., Tack, C. J., Netea, M. G., Joosten, L. A. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089615 · Cited by 20 · cited 2×
“These pathways could be linked to obesityinduced adipose tissue inflammation, but do not seem to have systemic effects on insulin resistance (Ballak et al. 2014).”
BackgroundGarris, D. R. (2005) · Pathobiology · doi:10.1159/000084115 · Cited by 10 · cited 4×
“Fat distribution changes with age so that there is an increase in visceral fat but also fat deposits occurs in skeletal muscle, the liver, heart and pancreas (Sakuma and Yamaguchi 2013; Wei et al. 2006; Shimabukuro et al. 1998; Sparangna and Hickson-bick 2000; Garris 2005; Summers 2006).”
BackgroundInfluential
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review
Li, C., Yu, K., Shyh‐Chang, N., Jiang, Z., Liu, T., Ma, S., Luo, L., Guang, L., Liang, K., Ma, W., et al. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12901 · Cited by 626
Heymsfield, S. B., Gonzalez, M. C., Lu, J., Jia, G., & Zheng, J. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665115000129 · Cited by 483
Mitochondria and ageing: Role in heart, skeletal muscle and adipose tissue
Boengler, K., Kosiol, M., Mayr, M., Schulz, R., & Rohrbach, S. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12178 · Cited by 421
Metadata
- Authors
- Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Paracelsus Medizinische Privatuniversität (DE)
- University Hospital Regensburg (DE)
- Universitätsmedizin Göttingen (DE)
- Corresponding author
- Fischer, Barbara E.
- ORCID
- Venue
- Biogerontology
- Published
- 2014-11-07
- Volume
- 16
- Issue
- 1
- Pages
- 15-29
- ISSN
- 1389-5729 (ISSN-L)
- 1573-6768
- OpenAlex
- W2087089023
- Cited by
- 151
- References
- 125
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 14 · 2023: 15 · 2022: 14 · 2021: 9 · 2020: 18 · 2019: 10 · 2018: 11 · 2017: 13 · 2016: 12 · 2015: 10
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Biogerontology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bayerische Forschungsstiftung
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- sarcopenic obesity, sarcopenia, obesity, pathogenesis, lipotoxicity, oxidative stress, apoptosis, inflammatory cytokines, C-reactive protein, interleukin-6, hypothalamic-pituitary axis, caloric restriction, insulin resistance, skeletal muscle, muscle progenitor cells, adipogenesis, muscle atrophy, aging
- MeSH terms
- Aging, Humans, Insulin Resistance, Obesity, Signal Transduction, Muscle, Skeletal, Muscle Weakness, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.